Copyright Reports & Markets. All rights reserved.

Global Metabolomics Reagents Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Metabolomics Reagents by Type
    • 1.3.1 Overview: Global Metabolomics Reagents Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Metabolomics Reagents Consumption Value Market Share by Type in 2025
    • 1.3.3 Targeted Metabolomics
    • 1.3.4 Untargeted Metabolomics
  • 1.4 Global Metabolomics Reagents Market by Application
    • 1.4.1 Overview: Global Metabolomics Reagents Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Biological Companies
    • 1.4.3 Research Institutions
    • 1.4.4 Educational Institutions
  • 1.5 Global Metabolomics Reagents Market Size & Forecast
  • 1.6 Global Metabolomics Reagents Market Size and Forecast by Region
    • 1.6.1 Global Metabolomics Reagents Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Metabolomics Reagents Market Size by Region, (2021-2032)
    • 1.6.3 North America Metabolomics Reagents Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Metabolomics Reagents Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Metabolomics Reagents Market Size and Prospect (2021-2032)
    • 1.6.6 South America Metabolomics Reagents Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Metabolomics Reagents Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Cambridge Isotope Laboratories
    • 2.1.1 Cambridge Isotope Laboratories Details
    • 2.1.2 Cambridge Isotope Laboratories Major Business
    • 2.1.3 Cambridge Isotope Laboratories Metabolomics Reagents Product and Solutions
    • 2.1.4 Cambridge Isotope Laboratories Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Cambridge Isotope Laboratories Recent Developments and Future Plans
  • 2.2 Biocrates
    • 2.2.1 Biocrates Details
    • 2.2.2 Biocrates Major Business
    • 2.2.3 Biocrates Metabolomics Reagents Product and Solutions
    • 2.2.4 Biocrates Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Biocrates Recent Developments and Future Plans
  • 2.3 IROA Technologies
    • 2.3.1 IROA Technologies Details
    • 2.3.2 IROA Technologies Major Business
    • 2.3.3 IROA Technologies Metabolomics Reagents Product and Solutions
    • 2.3.4 IROA Technologies Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 IROA Technologies Recent Developments and Future Plans
  • 2.4 Fluidome
    • 2.4.1 Fluidome Details
    • 2.4.2 Fluidome Major Business
    • 2.4.3 Fluidome Metabolomics Reagents Product and Solutions
    • 2.4.4 Fluidome Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Fluidome Recent Developments and Future Plans
  • 2.5 Metabolomix
    • 2.5.1 Metabolomix Details
    • 2.5.2 Metabolomix Major Business
    • 2.5.3 Metabolomix Metabolomics Reagents Product and Solutions
    • 2.5.4 Metabolomix Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Metabolomix Recent Developments and Future Plans
  • 2.6 Beijing BGI-GBI Biotech Co., Ltd. (GBI)
    • 2.6.1 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Details
    • 2.6.2 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Major Business
    • 2.6.3 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Product and Solutions
    • 2.6.4 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Recent Developments and Future Plans
  • 2.7 Metware Biotechnology
    • 2.7.1 Metware Biotechnology Details
    • 2.7.2 Metware Biotechnology Major Business
    • 2.7.3 Metware Biotechnology Metabolomics Reagents Product and Solutions
    • 2.7.4 Metware Biotechnology Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Metware Biotechnology Recent Developments and Future Plans
  • 2.8 BIOTERE
    • 2.8.1 BIOTERE Details
    • 2.8.2 BIOTERE Major Business
    • 2.8.3 BIOTERE Metabolomics Reagents Product and Solutions
    • 2.8.4 BIOTERE Metabolomics Reagents Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BIOTERE Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Metabolomics Reagents Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Metabolomics Reagents by Company Revenue
    • 3.2.2 Top 3 Metabolomics Reagents Players Market Share in 2025
    • 3.2.3 Top 6 Metabolomics Reagents Players Market Share in 2025
  • 3.3 Metabolomics Reagents Market: Overall Company Footprint Analysis
    • 3.3.1 Metabolomics Reagents Market: Region Footprint
    • 3.3.2 Metabolomics Reagents Market: Company Product Type Footprint
    • 3.3.3 Metabolomics Reagents Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Metabolomics Reagents Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Metabolomics Reagents Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Metabolomics Reagents Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Metabolomics Reagents Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Metabolomics Reagents Consumption Value by Type (2021-2032)
  • 6.2 North America Metabolomics Reagents Market Size by Application (2021-2032)
  • 6.3 North America Metabolomics Reagents Market Size by Country
    • 6.3.1 North America Metabolomics Reagents Consumption Value by Country (2021-2032)
    • 6.3.2 United States Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Metabolomics Reagents Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Metabolomics Reagents Consumption Value by Type (2021-2032)
  • 7.2 Europe Metabolomics Reagents Consumption Value by Application (2021-2032)
  • 7.3 Europe Metabolomics Reagents Market Size by Country
    • 7.3.1 Europe Metabolomics Reagents Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 7.3.3 France Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Metabolomics Reagents Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Metabolomics Reagents Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Metabolomics Reagents Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Metabolomics Reagents Market Size by Region
    • 8.3.1 Asia-Pacific Metabolomics Reagents Consumption Value by Region (2021-2032)
    • 8.3.2 China Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 8.3.5 India Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Metabolomics Reagents Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Metabolomics Reagents Consumption Value by Type (2021-2032)
  • 9.2 South America Metabolomics Reagents Consumption Value by Application (2021-2032)
  • 9.3 South America Metabolomics Reagents Market Size by Country
    • 9.3.1 South America Metabolomics Reagents Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Metabolomics Reagents Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Metabolomics Reagents Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Metabolomics Reagents Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Metabolomics Reagents Market Size by Country
    • 10.3.1 Middle East & Africa Metabolomics Reagents Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Metabolomics Reagents Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Metabolomics Reagents Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Metabolomics Reagents Market Drivers
  • 11.2 Metabolomics Reagents Market Restraints
  • 11.3 Metabolomics Reagents Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Metabolomics Reagents Industry Chain
  • 12.2 Metabolomics Reagents Upstream Analysis
  • 12.3 Metabolomics Reagents Midstream Analysis
  • 12.4 Metabolomics Reagents Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Metabolomics Reagents market size was valued at US$ 34.1 million in 2025 and is forecast to a readjusted size of US$ 79.06 million by 2032 with a CAGR of 12.9% during review period.
    Metabolomics reagents are specialized chemicals, compounds, or materials used in metabolomics research to detect, quantify, and analyse metabolites (small molecules) within biological systems. Metabolomics refers to an array of techniques used to comprehensively detect and analyse various metabolites formed in vivo during biological activity. The qualitative and quantitative changes in metabolites reflect the ever-changing biological phenomena and are widely used for diagnosis, biomarker discovery, and drug discovery research. In recent years, metabolomics has been used in the food industry to improve taste and quality and to develop functional foods. It is also used in the biotechnology industry to improve fermentation and biofuel productivity.
    Precision medicine aims to tailor treatments based on individual variability in genes, environment, and lifestyle. Metabolomics plays a critical role in identifying disease-specific biomarkers, leading to personalized treatment plans. This trend is accelerating the demand for reagents in clinical research and diagnostic applications.
    Pharmaceutical companies are leveraging metabolomics to better understand drug metabolism, efficacy, and toxicity. The demand for metabolomics reagents is rising as drug developers integrate metabolomics into preclinical and clinical phases to improve drug safety and efficacy profiles.
    MS and NMR are key analytical techniques used in metabolomics. Advancements in these technologies, such as increased sensitivity and higher resolution, are driving the need for high-quality reagents. The reagents market is benefitting from the growing adoption of these platforms in clinical labs and research institutions.
    Metabolomics is increasingly being combined with genomics, proteomics, and transcriptomics to provide a more comprehensive understanding of biological systems. This multi-omics approach is creating a need for reagents that can function across different platforms and deliver consistent results across studies.
    The cost of acquiring and maintaining advanced metabolomics platforms, such as mass spectrometry (MS) and nuclear magnetic resonance (NMR), is very high. The reagents used in these systems are often expensive as well, especially when using high-purity, specialized reagents. This high cost limits the accessibility of metabolomics tools to large, well-funded research institutions, pharmaceutical companies, and clinical labs, reducing its potential in smaller labs and emerging markets.
    There is a lack of standardized protocols and reagents across laboratories, which makes it difficult to compare results from different studies. Variability in reagents, instrument calibration, and experimental design can lead to inconsistent results, reducing confidence in metabolomics data. This inconsistency hampers efforts to establish metabolomics as a reliable tool in clinical diagnostics and large-scale studies.
    This report is a detailed and comprehensive analysis for global Metabolomics Reagents market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Metabolomics Reagents market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Metabolomics Reagents market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Metabolomics Reagents market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Metabolomics Reagents market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Metabolomics Reagents
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Metabolomics Reagents market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Cambridge Isotope Laboratories, Biocrates, IROA Technologies, Fluidome, Metabolomix, Beijing BGI-GBI Biotech Co., Ltd. (GBI), Metware Biotechnology, BIOTERE, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Metabolomics Reagents market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Targeted Metabolomics
    Untargeted Metabolomics
    Market segment by Application
    Biological Companies
    Research Institutions
    Educational Institutions
    Market segment by players, this report covers
    Cambridge Isotope Laboratories
    Biocrates
    IROA Technologies
    Fluidome
    Metabolomix
    Beijing BGI-GBI Biotech Co., Ltd. (GBI)
    Metware Biotechnology
    BIOTERE
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Metabolomics Reagents product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Metabolomics Reagents, with revenue, gross margin, and global market share of Metabolomics Reagents from 2021 to 2026.
    Chapter 3, the Metabolomics Reagents competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Metabolomics Reagents market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Metabolomics Reagents.
    Chapter 13, to describe Metabolomics Reagents research findings and conclusion.

    Buy now